Moderna (LTS:0A45) Machinery, Furniture, Equipment : $445 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Moderna Machinery, Furniture, Equipment?

Moderna's Machinery, Furniture, Equipment for the quarter that ended in Dec. 2023 was $445 Mil.

Moderna's quarterly Machinery, Furniture, Equipment increased from Jun. 2023 ($375 Mil) to Sep. 2023 ($415 Mil) and increased from Sep. 2023 ($415 Mil) to Dec. 2023 ($445 Mil).

Moderna's annual Machinery, Furniture, Equipment increased from Dec. 2021 ($211 Mil) to Dec. 2022 ($343 Mil) and increased from Dec. 2022 ($343 Mil) to Dec. 2023 ($445 Mil).

Moderna Machinery, Furniture, Equipment Historical Data

The historical data trend for Moderna's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Machinery, Furniture, Equipment Chart

Moderna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

130.58

146.00

211.00

343.00

445.00

Moderna Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Machinery, Furniture, Equipment	Get a 7-Day Free Trial															343.00	381.00	375.00	415.00	445.00

Moderna Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Moderna (LTS:0A45) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (LTS:0A45) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

MRNA:USA MRNA:Peru MRNA:Mexico 0QFd:UK 0QF:Germany M1RN34:Brazil MRNA:Austria

Address

200 Technology Square, Cambridge, MA, USA, 02139

Website

https://www.modernatx.com

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna (LTS:0A45) Headlines

No Headlines